The shares of The Michaels Companies, Inc. (NASDAQ:MIK) has been pegged with a rating of Underperform by BofA/Merrill in its latest research note that was published on July 19th, 2019. The research company has also assigned a $5 price target. BofA/Merrill wasn’t the only research firm that published a report of The Michaels Companies, Inc., with other equities research analysts also giving their opinion on the stock. Goldman advised investors in its research note published on July 11th, 2019, to Neutral the MIK stock while also putting a $8 price target. The stock had earned Market Perform rating from Telsey Advisory Group when it published its report on June 7th, 2019. That day the Telsey Advisory Group set price target on the stock to $9. The stock was given Neutral rating by Credit Suisse in its report released on June 7th, 2019, the day when the price target on the stock was placed at $11. Morgan Stanley was of a view that MIK is Equal-Weight in its latest report on May 20th, 2019 while giving it a price target of $10. Telsey Advisory Group thinks that MIK is worth Outperform rating. This was contained in the firm’s report on March 20th, 2019 in which the stock’s price target was also moved to $17.
The consensus currently stands at a Hold while its average price target is $9.90. The price of the stock the last time has raised by 26.21% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 52.91.
The shares of the company added by 11.79% during the trading session on Thursday, reaching a low of $5.91 while ending the day at $6.26. During the trading session, a total of 17.47 million shares were traded which represents a -451.14% decline from the average session volume which is 3.17M shares. MIK had ended its last session trading at 5.60. The Michaels Companies, Inc. currently has a market cap of $1.00B, while its P/E ratio stands at 3.10, while its P/E earnings growth sits at 0.19, with a beta of 1.05. MIK 52-week low price stands at $4.96 while its 52-week high price is $18.04.
Investment analysts at BofA/Merrill published a research note on August 20th, 2019 where it informed investors and clients that Bed Bath & Beyond Inc. (NASDAQ:BBBY) is now rated as Buy. Their price target on the stock stands at $20. Goldman also rated BBBY as Initiated on July 11th, 2019, with its price target of $51 suggesting that BBBY could surge by 33.52% from its current share price. Even though the stock has been trading at $9.33/share, analysts expect it to surge higher by 1.39% to reach $14.23/share. It started the day trading at $9.50 and traded between $9.14 and $9.46 throughout the trading session.
A look at its technical shows that BBBY’s 50-day SMA is 9.60 while its 200-day SMA stands at 13.27. At the moment, only of Bed Bath & Beyond Inc. shares were sold short. The company’s average trading volume currently stands at 6.86M shares, which means that the short-interest ratio is just 9.87 days. Over the past seven days, the company moved, with its shift of 16.79%. Looking further, the stock has dropped -26.55% over the past 90 days while it lost -39.12% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more BBBY shares, increasing its portfolio by +20.45% during the last quarter. This move now sees The Vanguard Group Inc purchasing 2,691,856 shares in the last quarter, thus it now holds 15,853,779 shares of BBBY, with a total valuation of $153,940,194. Fidelity Management Research Co meanwhile bought more BBBY shares in the recently filed quarter, changing its stake to $151,532,833 worth of shares. BlackRock Fund Advisors followed the path by decreasing its BBBY portfolio by -6.65% in the quarter. This means that BlackRock Fund Advisors sold -1,017,100 shares in the last quarter and now controls 14,281,278 shares of the BBBY stock, with the valuation hitting $138,671,209.
Similarly, Dimensional Fund Advisors LP decreased its Bed Bath & Beyond Inc. shares by -0.90% during the recently filed quarter. After selling -104,385 shares in the last quarter, the firm now controls 11,476,349 shares of Bed Bath & Beyond Inc. which are valued at $111,435,349. In the same vein, SSgA Funds Management Inc decreased its Bed Bath & Beyond Inc. shares by during the most recent reported quarter. The firm sold -6,821 shares during the quarter which decreased its stakes to 4,774,695 shares and is now valued at $46,362,288. Following these latest developments, around 2.70% of Bed Bath & Beyond Inc. stocks are owned by institutional investors and hedge funds.